| 產品名稱 |
Dengue virus type 2 |
| 商品貨號 |
B162928 |
| Classification |
Flaviviridae, Flavivirus, Dengue virus |
| Agent |
Dengue virus type 2 |
| Strain |
New Guinea C |
| Applications |
Vector borne research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen 1 mL per vial |
| Storage Conditions |
-70°C or colder |
| Comments |
Derived by adaptation from in vivo product ATCC® VR-1255™ to LLC-MK2 Derivative cells (ATCC® CCL-7.1™). ATCC® VR-1255™ and ATCC® VR-1584™ have not been compared for sequence or infectivity in in vivo and tissue culture. |
| Effect on Host |
CPE, cell aggregation, sloughing, death |
| Recommended Host |
LLC-MK2 Derivative (ATCC® CCL-7.1™) |
| Growth Conditions |
Temperature: 37°C
Recommendations for Infection: Plate cells 24-48 hours prior to infection and infect when cultures are 70-80% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 0.1). Adsorb 1-2 hours at 37°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 6-8 days |
| Name of Depositor |
CL Wisseman, University of Maryland School of Medicine; Yale Arbovirus Research Unit; National Institute of Allergy and Infectious Diseases; ATCC? |
| Source |
Serum of febrile patient, New Guinea, 1944 |
| References |
Sabin AB. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1: 30-50, 1952. PubMed: 14903434
|
